Cosmos Health Inc.

Contributing Author

Recent Articles by Cosmos Health Inc.

6 hours	Cosmos Health's C-Sept PRO Gains Strong Traction Across Leading Greek Public and Private Hospital Groups, With Annualized Sales Poised to Exceed $1.3 Million at Approximately 72% Gross Margin COSM GlobeNewswire
Jun-23	Cosmos Health Signs Agreement to Deploy Artificial Intelligence (AI)-Powered Call Center to Optimize Order Intake, Customer Communications, and Operating Efficiency COSM GlobeNewswire
Jun-22	Cosmos Health Builds Contract Manufacturing Orderbook to Over 25 Million Units; Division Positioned to Generate Over $10 Million in Recurring Annual Profit COSM GlobeNewswire
Jun-18	CosmoFarm Delivers Record Q2 2026 Revenue of Over $15M, Representing $60+ Million Annualized Run-Rate; Adds Over 80 Pharmacies and Expands AI Automation and Facility Capacity COSM -11.92% GlobeNewswire
Jun-17	Cosmos Health Enters the $163 Billion Global Skincare Market; Sales Already Underway in the United States COSM GlobeNewswire
Jun-17	Cosmos Health Signs 2.86 Million-Unit Contract Manufacturing Agreement With Pharmex S.A. Across Three Dermatological Products COSM GlobeNewswire
Jun-15	Cosmos Health Provides Update on United States Portfolio; Four 18 Series Products Introduced With Projected Annualized Revenue Over $22.7M and Approximately $17.0M Gross Profit COSM +12.90% GlobeNewswire
Jun-12	Cosmos Health Receives New Contract Manufacturing Orders Totaling 253,657 Units Across a Range of Medicines COSM GlobeNewswire
Jun-12	Cosmos Health Reports Annualized Sales Exceeding $1.5M for Its C-Scrub and C-Sept Antiseptic Brands in the UK and Greece; Plans EU Expansion Targeting $7.4M in Revenue and $5.3M in Gross Profit COSM GlobeNewswire
Jun-11	Cosmos Health Signs LOI to Acquire Doc Pharma S.A., a European GMP Pharmaceutical Manufacturer, a Transformative Step Expected to Boost Assets, Profitability, Production Capacity, and Product Portfolio COSM -9.69% GlobeNewswire
Jun-11	Cosmos Health Secures Additional 180-Day Nasdaq Extension to Regain Bid Price Compliance COSM -9.69% GlobeNewswire
Jun-10	Cosmos Health Signs 3-Year Contract Manufacturing Agreement with Verisfield for 3.9 Million Units of VASCLOR GEST Progesterone Pessaries COSM GlobeNewswire
Jun-10	Cosmos Health CEO Issues Letter to Shareholders: Building an Innovative AI-Driven Global Healthcare Platform - Record Growth with U.S. Expansion Underway COSM GlobeNewswire
Jun-09	Cosmos Health Inaugurates State-of-the-Art Capsule Production Line with New 5-Year Contract Manufacturing Agreement with Provident Pharmaceuticals for 385,000 Units of CERTORUN COSM GlobeNewswire
Jun-08	Cosmos Health Completes Acquisition of Strategic Intellectual Property and Expands Nanotechnology Investment Initiatives COSM -8.29% GlobeNewswire
Jun-05	Cosmos Health Continues U.S. Expansion with Launch of Oliv18, Targeting Cardiovascular and Antioxidant Categories COSM -7.42% GlobeNewswire
Jun-04	Cosmos Health Achieves Pan-European Distribution for Sky Premium Life Across All 27 EU Member States Through Leading E-Commerce Platform Skroutz COSM +9.81% GlobeNewswire
Jun-04	Cosmos Health Identifies Approximately $20 Million in Non-Core Assets Available for Monetization to Accelerate Growth and Unlock Shareholder Value COSM +9.81% GlobeNewswire
Jun-02	Cosmos Health Provides Balance Sheet Update: Highlights European Investment Bank Financing Discussions for up to 25M, Eliminates 38% of Warrant Overhang with No Dilution; Reaffirms Growth Trajectory; Notes No Known Business Reason for Recent Share Price Decline COSM GlobeNewswire
Jun-01	Cosmos Health Enters $69 Billion Global Animal Health Industry with Veterinary C-Scrub Wash 4% Following Successful European Standard Testing Under EN 1656 and EN 1657 COSM GlobeNewswire
May-26	Cosmos Health Releases 2026-2029 Guidance: Targeting $200M Revenue, $71M Gross Profit, and $44M Adjusted EBITDA by 2029 - Building an Innovative, High-Margin Healthcare Platform with Strong Cash Generation COSM GlobeNewswire
Mar-19	Cosmos Health Provides Update; Evaluates Options to Address Valuation Disconnect; Will Issue Updated Guidance Following FY 2025 Results; Record Growth Continues as Significant U.S. Expansion Underway, with Additional $12M+ in High-Margin Revenue Projected; Important R&D Updates Expected Following Finalization of Certain Anticipated Transactions COSM +9.56% COSM GlobeNewswire
Mar-11	Cosmos Health Purchases $600,000 of Bitcoin, Expands Digital Asset Holdings to $3,100,000 COSM GlobeNewswire
Mar-10	Cosmos Health Enters into LOI to Acquire $11,500,000 Pharmacy Distribution Network; Remains on Track to Deliver 2027 Revenue Guidance of $155,800,000 COSM -6.02% GlobeNewswire
Feb-24	Cosmos Health Appoints Globally Recognized AI-Driven Drug Discovery and Clinical-Stage Biotech Expert Dr. Dimitrios Iliopoulos to Advisory Board COSM +9.40% COSM GlobeNewswire
Feb-19	Cosmos Health Highlights Approximately $15 Million Fair Market Value of Real Estate Assets, Exceeding Current Market Capitalization; Evaluates Monetization Options to Address Significant Discount to Book Value COSM -5.88% GlobeNewswire
Feb-18	Cosmos Health Continues UK Retail Expansion for C-Scrub; Now Available at Superdrug, the UK's Second-Largest Beauty and Health Retailer COSM +9.53% GlobeNewswire
Feb-18	Cosmos Health Announces Growing Momentum for C-Scrub in the United Kingdom; Now Available at Tesco, the UK's Largest Retailer COSM +9.53% GlobeNewswire
Feb-17	Cosmos Health Showcases Expanding Brand Portfolio at World Health Expo Dubai 2026 COSM GlobeNewswire
Feb-11	Cosmos Health Expands Digital Assets Program with $500,000 Bitcoin Purchase, Bringing Total Cryptocurrency Investments to $2.5 Million; Evaluates Inclusion of Other Select Cryptocurrencies COSM -9.42% COSM GlobeNewswire
Jan-20	Cosmos Health Announces Accelerating Customer Growth, Improving Unit Economics and Robotic Expansion Supporting $40M in Additional Annual Revenue COSM -5.57% GlobeNewswire
Jan-14	Cosmos Health Announces Initiation of Analyst Coverage with $4.50 Valuation by Zacks Small-Cap Research COSM +21.53% COSM GlobeNewswire
Jan-05	Cosmos Health Enters Manufacturing Agreement with Libytec for PathMuscle Medicine, with Five-Year Volumes Expected to Exceed 1.2 Million Units COSM GlobeNewswire
Dec-03	Cosmos Health Launches Strategic Partnership With Prime Ledger to Transform $300M Treasury and Tokenize IP Assets COSM -10.81% GlobeNewswire
Dec-02	Cosmos Health CEO Greg Siokas Adds 3,398,055 Shares Year-to-Date 2025 Following Continued November Purchases COSM GlobeNewswire
Nov-17	Cosmos Health Reports Record Q3 2025 Results with All-Time High Revenue, Gross Profit and Gross Margin; Revenue Up 38% to $17.1M, Gross Profit Up 116% to $2.6M, Adjusted EBITDA Up 74%, Cash Position Up to $4.63M from $0.66M COSM GlobeNewswire
Oct-31	Cosmos Health Enters New Nanotechnology R&D Program to Develop Next-Generation Nutraceutical Formulas with Enhanced Phytochemical Efficacy COSM -10.01% GlobeNewswire
Oct-21	Cosmos Health Expands Its Ethereum Holdings With an Additional $200,000 Purchase Under Its $300 Million Digital Assets Facility; Total Investment Now Reaches $2 Million COSM GlobeNewswire
Oct-16	Cosmos Health Regains Compliance with Nasdaq Minimum Bid Price Requirement COSM -12.80% GlobeNewswire
Oct-13	Cosmos Health Purchases an Additional $300,000 in Ethereum Under Its $300 Million Digital Assets Facility; Total Investment Reaches $1.8 Million COSM +7.35% COSM GlobeNewswire
Oct-10	Cosmos Health Purchases an Additional $500,000 in Ethereum Pursuant to its $300 Million Digital Assets Facility COSM GlobeNewswire
Oct-03	Cosmos Health Expands Sky Premium Life Into $1Bn+ Kuwait Market; Signs Exclusive Distribution Agreement With Diyar United and Secures Initial Purchase Order of Over 65,000 Units COSM -5.56% COSM GlobeNewswire
Sep-29	Cosmos Health CEO Issues Letter to Shareholders: Building a Global Healthcare Powerhouse with $300M Digital Financing Facility, U.S. Manufacturing Expansion, and AI Innovation COSM GlobeNewswire
Sep-25	Cosmos Health Expands Order Book with Contract Manufacturing Agreement with Medical Pharmaquality S.A. for 3 Million MYCOFAGYL Pessaries Annually COSM GlobeNewswire
Sep-22	Cosmos Health Commences U.S. Operations, Entering $164B Nutraceuticals Market with Its Sky Premium Life Brand; Expects 75% Gross Margins and Strong Cash Flow, with NOOR Collagen Alone Projected to Generate Over $12M in Annualized Revenue COSM +15.39% GlobeNewswire
Sep-11	Cosmos Health Expands Presence in the $7 Billion GCC Nutraceuticals Market, Signs Distribution Agreement with Scientific Pharmacy for Sky Premium Life in Oman, Including Initial Purchase Order of 42,000 Units COSM +10.51% GlobeNewswire
Aug-18	Cosmos Health Reports Q2 2025 Results; Continues Strong Growth with 11.7% Revenue Increase; On Track to Meet Profitability Targets with Gross Profit Up 53% to $3.21M in H1 2025 COSM -5.27% GlobeNewswire
Aug-12	Cosmos Health Makes Initial $1M Ethereum Purchase Under Digital Asset Treasury Strategy COSM GlobeNewswire
Aug-06	Cosmos Health Secures up to $300 Million Financing Facility to Launch Ethereum Treasury Strategy COSM +30.98% GlobeNewswire
Jun-24	Cosmos Health Enters U.S. Market with Strategic Made-in-America Manufacturing, Mitigating Tariff Risks; Executes Agreement with New Jersey-Based DolCas Biotech COSM GlobeNewswire
May-15	RETRANSMISSION - Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross Profit Rises 54% to $2.05M; Operating Cash Burn Down 95%, or $3.2M, to $0.19M; Approaching Cash Flow Breakeven COSM GlobeNewswire
May-15	Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross Profit Rises 54% to $2.05M; Operating Cash Burn Down 95%, or $3.2M, to $0.19M; Approaching Cash Flow Breakeven COSM GlobeNewswire
May-07	Cosmos Health Secures Follow-Up Order from Pharmalink for 80,000 Sky Premium Life Units in the UAE; Initial 130,000-unit Order Sold Out, Advancing 5-Year Goal of Over 3 Million Units COSM GlobeNewswire
May-06	Cosmos Health Receives Additional 180-Day Compliance Period from Nasdaq COSM GlobeNewswire

Cosmos Health Inc.

Recent Articles by Cosmos Health Inc.

Upgrade your Finviz experience